A detailed history of Dfpg Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dfpg Investments, LLC holds 29,246 shares of NVO stock, worth $4.18 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
29,246
Previous 26,182 11.7%
Holding current value
$4.18 Million
Previous $2.38 Million 27.1%
% of portfolio
0.23%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$87.78 - $105.45 $268,957 - $323,098
3,064 Added 11.7%
29,246 $3.03 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.36 Million - $2.98 Million
14,944 Added 132.98%
26,182 $2.38 Million
Q2 2023

Jul 24, 2023

BUY
$155.98 - $172.65 $296,362 - $328,035
1,900 Added 20.35%
11,238 $1.82 Million
Q1 2023

Apr 10, 2023

BUY
$132.34 - $159.14 $80,727 - $97,075
610 Added 6.99%
9,338 $1.49 Million
Q4 2022

Feb 02, 2023

BUY
$102.55 - $135.33 $895,056 - $1.18 Million
8,728 New
8,728 $1.18 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.